>
UN, Gates digital ID, fast payments, data sharing 50-in-5 campaign hits 30 countries
Health Benefits of Topical Magnesium Lotions and Sprays
Big Banks Prepare for Compliance Based Currency
Stop 'Rooting For Failure' In Gaza: Vance In Israel Lambasts Western Media
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
Millions Of America's Teens Are Being Seduced By AI Chatbots
Transhumanist Scientists Create Embryos From Skin Cells And Sperm
You've Never Seen Tech Like This
Sodium-ion battery breakthrough: CATL's latest innovation allows for 300 mile EVs
Defending Against Strained Grids, Army To Power US Bases With Micro-Nuke Reactors
With promising early results, the researchers say their findings could usher in trials where such transplantations are put to the test in humans.
Stem cells have shown exciting potential in improving the vision of patients with degenerative eye disorders for years. In 2010, scientists reported the creation of the first early-stage retina engineered with human embryonic stem cells. Then in 2012, two legally blind patients experienced improvements to their vision after receiving transplants of retinal cells, also derived from human embryonic stem cells.
But what sets this latest achievement apart is that scientists from Osaka and Cardiff University's were able to use human stem cells to reproduce something closer to the complex nature of the entire eyeball. Using induced pluripotent stem cells, or cells derived directly from adult cells, they were able to cultivate multiple cell lineages of the eye, including the lens, cornea and conjunctiva.